Rankings
▼
Calendar
BOLD Q3 2016 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$40M
Net Income
-$40M
EPS (Diluted)
$-5.74
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$16M
Stock-Based Comp.
$599,000
Balance Sheet
Total Assets
$159M
Total Liabilities
$20M
Stockholders' Equity
$138M
Cash & Equivalents
$87M
← FY 2016
All Quarters
Q4 2016 →